Lefaucheur J-P, Drouot X, Menard-Lefaucheur I, Zerah F, Bendib B, Cesaro P, Keravel Y, Nguyen J-P
Service de Physiologie-Explorations Fonctionnelles, Hôpital Henri Mondor, 51 Avenue de Lattre de Tassigny, 94010 Créteil, France.
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):612-6. doi: 10.1136/jnnp.2003.022236.
Drug resistant neurogenic pain can be relieved by repetitive transcranial magnetic stimulation (rTMS) of the motor cortex. This study was designed to assess the influence of pain origin, pain site, and sensory loss on rTMS efficacy.
Sixty right handed patients were included, suffering from intractable pain secondary to one of the following types of lesion: thalamic stroke, brainstem stroke, spinal cord lesion, brachial plexus lesion, or trigeminal nerve lesion. The pain predominated unilaterally in the face, the upper limb, or the lower limb. The thermal sensory thresholds were measured within the painful zone and were found to be highly or moderately elevated. Finally, the pain level was scored on a visual analogue scale before and after a 20 minute session of "real" or "sham" 10 Hz rTMS over the side of the motor cortex corresponding to the hand on the painful side, even if the pain was not experienced in the hand itself.
and discussion: The percentage pain reduction was significantly greater following real than sham rTMS (-22.9% v -7.8%, p = 0.0002), confirming that motor cortex rTMS was able to induce antalgic effects. These effects were significantly influenced by the origin and the site of pain. For pain origin, results were worse in patients with brainstem stroke, whatever the site of pain. This was consistent with a descending modulation within the brainstem, triggered by the motor corticothalamic output. For pain site, better results were obtained for facial pain, although stimulation was targeted on the hand cortical area. Thus, in contrast to implanted stimulation, the target for rTMS procedure in pain control may not be the area corresponding to the painful zone but an adjacent one. Across representation plasticity of cortical areas resulting from deafferentation could explain this discrepancy. Finally, the degree of sensory loss did not interfere with pain origin or pain site regarding rTMS effects.
Motor cortex rTMS was found to result in a significant but transient relief of chronic pain, influenced by pain origin and pain site. These parameters should be taken into account in any further study of rTMS application in chronic pain control.
运动皮层的重复经颅磁刺激(rTMS)可缓解耐药性神经源性疼痛。本研究旨在评估疼痛起源、疼痛部位和感觉丧失对rTMS疗效的影响。
纳入60名右利手患者,他们患有以下类型病变之一继发的顽固性疼痛:丘脑卒中、脑干卒中、脊髓损伤、臂丛神经损伤或三叉神经损伤。疼痛主要单侧出现在面部、上肢或下肢。在疼痛区域内测量热感觉阈值,发现其显著或中度升高。最后,在对应于疼痛侧手部的运动皮层一侧进行20分钟的“真实”或“假”10Hz rTMS治疗前后,使用视觉模拟量表对疼痛程度进行评分,即便疼痛并非出现在手部本身。
与假rTMS相比,真实rTMS后疼痛减轻的百分比显著更高(-22.9%对-7.8%,p = 0.0002),证实运动皮层rTMS能够产生镇痛效果。这些效果受到疼痛起源和部位的显著影响。对于疼痛起源,无论疼痛部位如何,脑干卒中患者的结果更差。这与由运动皮质丘脑输出触发的脑干内下行调制一致。对于疼痛部位,面部疼痛取得了更好的结果,尽管刺激针对的是手部皮质区域。因此,与植入式刺激不同,rTMS用于疼痛控制的靶点可能不是对应疼痛区域的部位,而是相邻部位。去传入导致的皮质区域跨表征可塑性可以解释这种差异。最后,感觉丧失程度在rTMS效果方面不影响疼痛起源或疼痛部位。
发现运动皮层rTMS可导致慢性疼痛显著但短暂的缓解,受疼痛起源和部位影响。在rTMS应用于慢性疼痛控制的任何进一步研究中都应考虑这些参数。